Articles of note for people dealing with pituitary disease and related conditions.
The latest from pharmaceutical companies and healthcare organizations
Brief, insightful commentary from Dr. Lewis Blevins on issues of relevance to pituitary disease.
ENDO 2025: Adrenalectomy Benefits for People with Mild Autonomous Cortisol Secretion (MACS)
Dr. Lewis Blevins talks with Dr. Iacopo Chiodini at The Endocrine Society Meeting in San Francisco, California to discuss his presentation illustrating the benefits of adrenalectomy in patients with MACS. In this video, capturing the presentation of data, they also discuss the need for studies to address the medical management of patients with MACS.
Cortisol and type 2 diabetes: interviews from ENDO 2025
Numerous studies have suggested that hypercortisolism is present in 3-8 percent of unselected patients with type 2 diabetes mellitus. Recent data from the Catalyst study suggest that hypercortisolism may be seen in as many as one-quarter of patients with uncontrolled type 2 diabetes...
Worth noting:
Recordati announces FDA approval of ISTURISA® new indication in the U.S. to treat endogenous hypercortisolemia in patients with Cushing’s syndrome,- Learn more here
Corcept Therapeutics announces FDA Relacolirant new drug application to treat Hypercortisolism . Read more
From Crinetics Pharmaceuticals – FDA accepts Crinetics new drug Paltusotine’s application for adults with acromegaly . Read more
Camurus announces final results for the once-monthly octreotide subcutaneous treatment option for acromegaly. Read more
New support site from Chiesi; Rethink acromegaly
Pfizer announces Together with Acromegaly patient support site and Together for Rare: Understanding your insurance options video.
Chiesi relaunches a patient-facing website for Mycapssa.
Content for physicians and healthcare professionals.
Join a drug trial. Find out how. Here’s a partial list of studies.
Latest trends and a roundup of health and wellness news
The Podcast
Knowledge and information are critical tools to affect early diagnosis in pituitary disease. Join Dr. Lewis Blevins and Jorge D Faccinetti cofounders, as they navigate the wonders and complexities of pituitary conditions.
Live Talk on Demand
I recently had the pleasure of meeting Camurus CEO Fredrik Tiberg. We initially connected on a Zoom call and later met at the European Endocrine Conference held in Copenhagen, Denmark in May. We agreed to meet in person, learn more about the company and record a podcast.
Apple Podcasts
Spotify
Amazon Music
Google Podcasts
